Nicoletta Botto

Nicoletta Botto

Auto-generated profile, based on publicly available information

Nicoletta Botto

Fondazione Toscana Gabriele Monasterio, 56124 Pisa, Italy

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2013 in BMC Medical Genetics
Verified
Journal Article
Open access
PDF file
IFIlenia Foffa
Ilenia Foffa
LALamia Ait-Ali
Lamia Ait-Ali
PPPaola Panesi
Paola Panesi
MMMassimiliano Mariani
Massimiliano Mariani
PFPierluigi Festa
Pierluigi Festa
Maria Grazia AndreassiMaria Grazia Andreassi
Maria Grazia Andreassi
Background: The purpose of our study was to investigate the potential contribution of germline mutations in NOTCH1, GATA5 and TGFBR1 and TGFBR2 genes in a cohort of Italian patients with familial Bicuspid Aortic Valve (BAV). Methods: All the coding exons including adjacent intronic as well as 5′ and 3′ untranslated (UTR) sequences of NOTCH1, GATA5, TGFBR1 and TGFBR2 genes were screened by direct gene sequencing in 11 index patients (8 males; age = 42 ± 19 years) with familial BAV defined as two or more affected members. Results: Two novel mutations, a missense and a nonsense mutation (Exon 5, p.P284L; Exon 26, p.Y1619X), were found in the NOTCH1 gene in two unrelated families. The mutations segregated with the disease in these families, and they were not found on 200 unrelated chromosomes from ethnically matched controls. No pathogenetic mutation was identified in GATA5, TGFBR1 and TGFBR2 genes. Conclusions: Two novel NOTCH1 mutations were identified in two Italian families with BAV, highlighting the role of a NOTCH1 signaling pathway in BAV and its aortic complications. These findings are of relevance for genetic counseling and clinical care of families presenting with BAV. Future studies are needed in order to unravel the still largely unknown genetics of BAV.

30 July 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
VCVincenzo Castiglione
Vincenzo Castiglione
MMMartina Modena
Martina Modena
AAAlberto Aimo
Alberto Aimo
ECEnrica Chiti
Enrica Chiti
NBNicoletta Botto
Nicoletta Botto
MEMichele Emdin
Michele Emdin
Molecular autopsy is the process of investigating sudden death through genetic analysis. It is particularly useful in cases where traditional autopsy is negative or only shows non-diagnostic features, i.e., in sudden unexplained deaths (SUDs), which are often due to an underlying inherited arrhythmogenic cardiac disease. The final goal of molecular autopsy in SUD cases is to aid medico-legal inquiries and to guide cascade genetic screening of the victim’s relatives. Early attempts of molecular autopsy relied on Sanger sequencing, which, despite being accurate and easy to use, has a low throughput and can only be employed to analyse a small panel of genes. Conversely, the recent adoption of next-generation sequencing (NGS) technologies has allowed exome/genome wide examination, providing an increase in detection of pathogenic variants and the discovery of newer genotype-phenotype associations. NGS has nonetheless brought new challenges to molecular autopsy, especially regarding the clinical interpretation of the large number of variants of unknown significance detected in each individual.